Navigation Links
Dana-Farber Cancer Institute Completes Deployment of MedAptus' Infusion Services Module
Date:2/13/2008

Solution Yields Streamlined, Compliant Coding of Nearly 90,000 Annual

Infusion Visits

BOSTON, Feb. 13 /PRNewswire/ -- MedAptus(R), the leading provider of point-of-care charge capture technologies, today announced that its customer, the prestigious Dana-Farber Cancer Institute, has completed enterprise-wide deployment of the company's Infusion Services Module.

The Module, an extension of MedAptus' revenue-enhancing Facility Charge Capture solution, supports the compliant capture of infusion services and related charges. The application also includes powerful administrative tools that provide real-time revenue cycle visibility as well as exception-based charge management and reconciliation.

Boston-based Dana-Farber is a principal teaching affiliate of the Harvard Medical School and is among the leading cancer research and care centers in the United States. The organization first implemented MedAptus' Professional Charge Capture solution, via Physician Workstation, in July of 2006. Within five months, approximately 300 physicians and midlevel providers were using the desktop-based version of the software to enter more than 3,000 outpatient charges on a weekly basis.

Given the success of Dana-Farber's Physician Workstation implementation for professional charges, the organization sought similar automation to streamline coding for facility charges related to infusion visits. An additional desire was for functionality that would automatically translate what nurses enter for infusion services delivered into compliant codes based on the organizational charge data master. Working collaboratively, MedAptus and Dana-Farber personnel developed the Infusion Services Module as an add-on to Facility Charge Capture, enabling the nurses to focus on patient care and not on the constantly changing regulations governing infusion billing.

"Until we implemented the Infusion Services Module, our nurses relied on paper encounter forms to capture infusion charges. Not only were the visits themselves complex, requiring multiple therapies and involving multiple nurses, but the overhead to redesign encounter forms, retrain nurses and monitor compliance resulting from annual regulatory changes was extremely high. Now that we have technology in place to support the charge capture process and automate updates related to annual changes, our nurses are able to focus more on the care of the patient and less on administrative demands," said Lori Buswell, RN, MS, CS, OCN, director, nursing patient care services/clinical operations and decision support, Dana-Farber Cancer Institute. She further added that throughout the phased in roll-out, during the first week of usage, more than 95 percent of captured charges were ready for export by the following morning, greatly reducing charge lag.

The Infusion Services Module was fully deployed to Dana-Farber's 120 infusion nurses across its Boston locations in less than 90 days. Completion of this deployment means that MedAptus technology is now used for point-of- care charge capture related to Dana-Farber's nearly 200,000 annual outpatient visits, roughly 90,000 of which include infusions.

"We are honored to have worked so closely with Dana-Farber on a solution that effectively eliminates the regulatory headaches that have increasingly burdened clinical staff involved in the delivery of infusion services. And of tremendous organizational benefit are the revenue capture rules which provide real-time feedback at the point-of-care to ensure accurate and complete capture of services, medications and supplies," said David Delaney, MD, chief medical officer of MedAptus. "Dana-Farber was an excellent development partner, providing tremendous input around our Infusion product's functionality. We applaud their keen insights and their ability to rapidly - and successfully - implement new technologies."

About MedAptus Corporation

MedAptus believes that in order for point-of-care technologies to make sense, they must be easy to use, deliver demonstrable returns and also leverage an organization's current information technology investments. MedAptus' Revenue Cycle Management suite of products includes both Professional and Facility Charge Capture; the company also offers complementary clinical applications such as Dictation, Clinical Content, Electronic Prescribing, and Clinical Results. Enterprises that have deployed MedAptus solutions have realized millions of dollars in increased revenue, improved organizational productivity, and enjoyed enthusiastic user adoption. For more information, visit http://www.medaptus.com or call 617.523.1221.

MedAptus Contact:

Jennifer Crowley

p. 617.896.4030

jcrowley@medaptus.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE MedAptus Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Corey McPherson Nash Develops Case Statement for Dana-Farber Cancer Institute Capital Campaign
2. Kidney Cancer Drug Linked to Higher Rate of Heart Problems
3. Bioniche Provides Update on Refractory Bladder Cancer Trial with Urocidin(TM)
4. HPV-positive head and neck cancer patients fare better than HPV-negative patients
5. DCIS patients overestimate breast cancer risks
6. Anxiety linked to newly diagnosed DCIS patients overestimation of breast cancer risks
7. HPV-Positive Head and Neck Cancers Fare Better
8. Precancerous Breast Lesions Cause Unnecessary Worry
9. New Jefferson trial to test radiation-emitting beads against advanced liver cancer
10. Yale test detects early stage ovarian cancer with 99 percent accuracy
11. Chicago Tribune Does Story on Canine Cancer, Morris Animal Foundation (MAF) Effort to Find a Cure - MAF Can Provide Information - Local Angles for a Feature Story
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop ... The fitness app plans to fix the two major problems leading the fitness industry today:, ... all type program , They don’t eliminate all the reasons people quit their ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... CAMBRIDGE, Mass. , June 24, 2016 /PRNewswire/ ... the Spaulding Rehabilitation Network,s Dean Center for ... of Physical Medicine and Rehabilitation, MIT Hacking Medicine, ... Center for Innovation, today announced the five finalists ... Hackathon for Lyme disease.  More than 100 scientists, ...
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: DHRM ) ... medical devices and wearable sleep respiratory products in ... with Hongyuan Supply Chain Management Co., Ltd. (hereinafter referred ... to develop Dehaier,s new Internet medical technology business. ... Hongyuan Supply Chain,s sales platform to reach Dehaier,s dealers ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
Breaking Medicine Technology: